Every year, more than 3,000 scientific abstracts are accepted for oral and poster presentation at the Society's annual meeting.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.
Although Congress reached an agreement to
temporarily fund federal agencies and programs – including NIH – through the
first several months of fiscal year (FY) 2015, another short-term or full-year
funding bill must be passed prior to December 11 to keep the federal government
operational and avoid a government shutdown. Until a final deal is
reached, additional cuts in funding for NIH remain a possibility.
On February 6, 2014 the leadership of the House Ways and Means and Energy and Commerce Committees and the Senate Finance Committee released a bi-partisan and bicameral bill to repeal the Sustainable Growth Rate (SGR) formula that has driven annual reductions in Medicare payment for physician services. Your advocacy is needed to ensure that the legislation can be considered by the full House of Representatives and Senate before the short-term physician fee update expires on April 1, 2014.
The ASH Practice Partnership (APP) hosted its annual luncheon event at the 2014 ASH Annual Meeting in San Francisco on Sunday, December 7. This year's topic was "Whither the Practice of Hematology in an Era of Mergers?" Read more to hear about the speakers and presentation.
As the 113
Congress winds down, it has become clear that this group of legislators will not be remembered as the one that permanently addressed the issues associated with Medicare physician payment. Read more to find out what may happen with the SGR in 2015.
Conference on Clinical Cancer Research brought together leaders in cancer drug
development from federal, health and regulatory agencies, academic research and
the private sector for focused discussions on critical issues surrounding the
development and regulation of cancer drugs and therapies.
The National Heart, Lung and Blood Institute (NHLBI) is now accepting applications for
Research Project Grants and
Small Business Technology Transfer Grants that will support research addressing scientific questions to enable and accelerate the use of stem cell-derived blood products as therapeutics. The application deadlines for these funding opportunities is February 15 and February 20, 2015, respectively.
Support the mission of ASH and help move hematology forward.
Become part of a global network of more than 15,000 hematologists working to conquer blood diseases.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology